Doxorubicin inhibits DNMT1, resulting in conditional apoptosis

Molecular Pharmacology
Tomoki Yokochi, Keith D Robertson

Abstract

Chemotherapy using DNA intercalators is one of the most successful approaches to cancer treatment. Although DNA intercalators are believed to inhibit DNA polymerases and topoisomerases, resulting in the induction of apoptosis in tumor cells, other factors potentially inhibited by the anthracycline antibiotics remain to be elucidated. Herein, we show that the enzymatic activity of DNMT1, the primary DNA methyltransferase in mammalian cells, is inhibited by DNA intercalators, such as doxorubicin, in an in vitro assay. Enzymatic analyses indicate that doxorubicin inhibits the catalytic activity of DNMT1 via DNA intercalation. We also found that apoptosis was induced in DNMT1(+/+) HCT116 cells by only a limited range of doxorubicin dose, meaning that apoptotic cell death is "conditional" with respect to the concentration of the DNA intercalating drug. It is noteworthy that conditional apoptosis is not observed in human colorectal cancer cells lacking DNMT1 but can be induced in DNMT1(-/-) cells by transfection of a plasmid expressing DNMT1. Our results suggest that DNMT1 is one of the major targets of doxorubicin resulting in drug-induced apoptosis in human cancer cells. We propose that expression levels of DNMT1 in tumor cells may...Continue Reading

References

Sep 1, 1976·Cancer Treatment Reviews·L Lenaz, J A Page
Dec 1, 1975·Journal of the National Cancer Institute·S K Carter
Sep 1, 1992·Cancer Metastasis Reviews·J A Hickman
May 11, 1987·FEBS Letters·R L Adams, A Rinaldi
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Dec 6, 1996·The Journal of Biological Chemistry·J A YoderS B Baylin
Apr 29, 1998·Annual Review of Physiology·G KroemerM Resche-Rigon
Jul 29, 1999·Journal of Molecular and Cellular Cardiology·R J BoucekD A Dodd
Dec 28, 1999·Annual Review of Cell and Developmental Biology·I BudihardjoX Wang
Jun 23, 2001·Oncogene·K D Robertson
Sep 20, 2001·Current Pharmaceutical Design·M F BrañaA Ramos
Feb 1, 2002·The Journal of Biological Chemistry·Tomoki Yokochi, Keith D Robertson
Apr 5, 2002·Nature·Ina RheeBert Vogelstein
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Aug 3, 2002·Oncogene·Melanie Ehrlich
Oct 26, 2002·BioTechniques·Michael C Yeung
Nov 6, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Frederick L Kiechle, Xinbo Zhang
Sep 13, 2003·Pharmacology & Toxicology·Kendall B Wallace

❮ Previous
Next ❯

Citations

Sep 30, 2005·Cancer Immunology, Immunotherapy : CII·F L ZhouS H Liu
Sep 14, 2011·Journal of the American Chemical Society·Santimukul SantraJ Manuel Perez
Mar 18, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Debendranath BanerjeeR S K Chaganti
Nov 18, 2009·Biochemistry. Biokhimii︠a︡·O V KirsanovaE S Gromova
Jan 13, 2010·Reproductive Biology and Endocrinology : RB&E·Vanessa VendraminiSandra M Miraglia
Dec 22, 2007·Molecular Endocrinology·Jie ZhouWen Xie
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Marin VeldicErminio Costa
Feb 12, 2011·Oxidative Medicine and Cellular Longevity·Sabry M AttiaNouf M Al-Rasheed
Jun 16, 2012·Physical Chemistry Chemical Physics : PCCP·Ane EizaguirreLeif A Eriksson
Aug 20, 2015·Medicinal Research Reviews·Benny J EvisonSuzanne M Cutts
Jul 24, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·H MalekinejadS Varasteh
Dec 19, 2015·Journal of Pharmaceutical and Biomedical Analysis·Andrew T LucasWilliam C Zamboni
May 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Simran PreetPraveen Rishi
Jul 23, 2005·IUBMB Life·Suzanne M CuttsDon R Phillips
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Yu ZhangBaiqu Huang
May 3, 2015·Carbohydrate Polymers·Somkamol ManchunPornsak Sriamornsak
May 13, 2014·The International Journal of Biochemistry & Cell Biology·Tsai-Hsien HungKowit Yu Chong
Oct 1, 2013·Free Radical Biology & Medicine·Cathrine Elisabeth OlsenAnette Weyergang
Sep 20, 2011·European Journal of Pharmacology·Amalia AzzaritiAngelo Paradiso
Mar 19, 2009·Biochemical and Biophysical Research Communications·Hwee Hong Tan, Alan George Porter
Jun 14, 2016·BioMed Research International·Estela G TorañoAgustín F Fernández
Jun 19, 2016·Journal of Biomaterials Science. Polymer Edition·Manisha JassalSankha Bhowmick
Jul 5, 2016·International Journal of Biological Macromolecules·Manu M JosephSreelekha T T
Mar 7, 2008·Nature·Sara KangaspeskaGeorge Reid
Apr 10, 2010·Journal of Applied Physiology·Oscar AguileraMario F Fraga
Sep 26, 2012·International Journal of Molecular Medicine·Steven G GrayKenneth J O'Byrne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.